Bristol-Myers Squibb (BMY) Stock Jumps 8% as FDA Approves Psoriasis Treatment

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Sotyktu's Phase 3 study showed it more effective than Amgen's Otezla for treating psoriasis.

The post Bristol-Myers Squibb (BMY) Stock Jumps 8% as FDA Approves Psoriasis Treatment appeared first on InvestorPlace.

• Buy This $5 Stock BEFORE This Apple Project Goes Live
• The Best $1 Investment You Can Make Today
• Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
• It doesn’t matter if you have $500 or $5 million. Do this now.